MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1 st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development ...

Q1 2025 Earnings Call Transcript May 14, 2025 Monogram Orthopaedics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. Larry Holub: Good afternoon, everyone, and ...

We still have 27 full-time employees that are supporting our ongoing R&D and getting ... quarter for Monogram. On March 17th, we were pleased to announce that we had received 510(k) clearance ...

The R&D decrease was Completed all Supplemental ... Update On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission to the FDA for the ...

Special thanks to Ani Nayak, Senior Manager of Clinical R&D, for his support ... being explored. Monogram has obtained FDA clearance for mPress implants and applied for 510(k) clearance for ...

Special thanks to Ani Nayak, Senior Manager of Clinical R&D, for his support ... being explored. Monogram has obtained FDA clearance for mPress implants and applied for 510(k) clearance for ...

While he is not admitted to practice in Washington, D.C., Schnurer ... a partner at K&L Gates for nearly five years and has also worked in-house as associate general counsel for Monogram ...

The show includes his tailcoat of brushed wool, as well as a shirt embroidered with a “D” monogram, a top hat, a cane and a pair of sunglasses. One of Miller’s favorite items in the heritage section ...

She’s only 23, but the young actor’s been working in the movies—particularly Telugu cinema—for nearly eight years, and has ...